Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Educational and Cultural Engagement and Incidence of Health Adverse Events

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03987360
Recruitment Status : Not yet recruiting
First Posted : June 17, 2019
Last Update Posted : June 18, 2019
Sponsor:
Information provided by (Responsible Party):
Olivier Beauchet, Jewish General Hospital

Brief Summary:
This study evaluated if the social and cultural activities decrease the incidence of dementia and frailty conditions.

Condition or disease Intervention/treatment
Older Adults Depression Cognitive Decline Other: Observational

Detailed Description:
The past decade has been characterized by the involvement of Museums in individual health prevention and promotion by using art-based activities to improve quality of life and well-being. Visiting museum or over cultural and educational activity could be used for health prevention and promotion. For the development of appropriate educational and cultural activities, there is a need, first, to improve knowledge about social and health condition of older adult, and second to examine the effects of engagement in educational and social activity on incidence of health adverse events.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 30000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Educational and Cultural Engagement and Incidence of Health Adverse Events: Results From the Canadian Longitudinal Study on Aging
Estimated Study Start Date : August 31, 2019
Estimated Primary Completion Date : May 31, 2020
Estimated Study Completion Date : July 31, 2021

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: Observational
    Participants who attended different educational and cultural activities either in a community centers or public institutions like arts museums or universities.


Primary Outcome Measures :
  1. Depression [ Time Frame: around 20 years ]
    It will be used the Depression scale which has a score of 10 or less. Each participant will be asses based on this scale. The depression scale evaluates the depression symptoms for a time period.


Secondary Outcome Measures :
  1. Motoric cognitive risk syndrome [ Time Frame: around 20 years ]
    Motoric cognitive risk syndrome represents a pre-dementia syndrome characterized by cognitive complaints and a slow gait speed.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People from Canada who participate in the Canadian Longitudinal Study on Aging. Participants who have the habits to go to museums for art classes, workshops, guided visits, and others arts activities. Participants of Canadian Longitudinal Study on Aging who are involved in art and educational activities in their communities.
Criteria

Inclusion Criteria:

  • Being 50 years and over
  • Being enrolled in the Canadian Longitudinal Study on Aging
  • Actively involved in social and cultural activities

Exclusion Criteria:

  • Never enrolled in the Canadian Longitudinal Study on Aging
  • Less than 50 years old

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03987360


Contacts
Layout table for location contacts
Contact: Kevin Galery (+1) 514-340-8222 ext 27494 kevin.galery@mail.mcgill.ca

Locations
Layout table for location information
Canada, Quebec
Jewish General Hospital
Montréal, Quebec, Canada, H3T 1E2
Sponsors and Collaborators
Jewish General Hospital
Investigators
Layout table for investigator information
Principal Investigator: Olivier Beauchet, MD Jewish General Hospital

Layout table for additonal information
Responsible Party: Olivier Beauchet, MD, Professor of Geriatrics, Jewish General Hospital
ClinicalTrials.gov Identifier: NCT03987360     History of Changes
Other Study ID Numbers: 2020-1842
First Posted: June 17, 2019    Key Record Dates
Last Update Posted: June 18, 2019
Last Verified: June 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders